PDL1 Monoclonal Antibody-Modified mPEG–PLGA-NH 2 Nanocomposite Loaded with Heterophyllin B for the Treatment of Gastric Cancer
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c01343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yunhai Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University; Huzhou Cen…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Polyethylene Glycols, B7-H1 Antigen, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Zhejiang Province Public Welfare Technology Application Research Project, Zhejiang Chinese Medical University.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) show effectiveness in gastric cancer (GC) treatment, yet enhancing their efficacy remains challenging. We encapsulated the anticancer compound Heterophyllin B (HB) in mPEG-PLGA-NH2 nanoparticles (NPs), modified with αPDL1, forming mPEG-PLGA-NH2@HB-αPDL1 NPs. These NPs displayed low toxicity to GES-1 cells and good blood compatibility. They effectively inhibited GC cell malignant phenotypes and downregulated PD-L1 expression via the PI3K/AKT pathway. In GC allograft mice, the HB and αPDL1 combination therapy outperformed monotherapy, with the NPs showing better efficacy than free drugs. Additionally, the NPs improved the tumor immune microenvironment. H&E staining confirmed no significant toxicity to major mouse organs. Thus, mPEG-PLGA-NH2@HB-αPDL1 offers a promising strategy for optimizing ICI therapy in GC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University; Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzho…
- Department of Gastrointestinal Surgery, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou 313000, China.
ORCID-Profile: Yunhai Wei
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Zhejiang Province Public Welfare Technology Application Research Project
- Zhejiang Chinese Medical University
Zitieren
APA
Wei, Y., Hu, W., Guo, H., Zhang, J., Cao, J., Shen, C., Wu, Z., Yin, L., & Gao, Y. (2025). PDL1 Monoclonal Antibody-Modified mPEG–PLGA-NH 2 Nanocomposite Loaded with Heterophyllin B for the Treatment of Gastric Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01343
Vancouver
Wei Y, Hu W, Guo H, Zhang J, Cao J, Shen C, et al. PDL1 Monoclonal Antibody-Modified mPEG–PLGA-NH 2 Nanocomposite Loaded with Heterophyllin B for the Treatment of Gastric Cancer. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01343
BibTeX
@article{Wei2025,
author = {Wei, Yunhai and Hu, Wenjing and Guo, Huancen and Zhang, Jinyu and Cao, Jingrui and Shen, Chu and Wu, Zhongxin and Yin, Lei and Gao, Yuhai},
title = {PDL1 Monoclonal Antibody-Modified mPEG–PLGA-NH 2 Nanocomposite Loaded with Heterophyllin B for the Treatment of Gastric Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c01343}
}
EUVIMED